These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28389110)

  • 41. Semisynthesis of ent-norstrobane diterpenoids as potential inhibitor for factor Xa.
    Wang J; Ma H; Fu H
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3813-3815. PubMed ID: 30340898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and evaluation of acylguanidine FXa inhibitors.
    O'Connor SP; Atwal K; Li C; Liu EC; Seiler SM; Shi M; Shi Y; Stein PD; Wang Y
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4696-9. PubMed ID: 18644722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting.
    Zhu Y; Li R; Lin Y; Shui M; Liu X; Chen H; Wang Y
    Sci Rep; 2016 Jul; 6():29895. PubMed ID: 27432161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
    Buckman BO; Mohan R; Koovakkat S; Liang A; Trinh L; Morrissey MM
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2235-40. PubMed ID: 9873520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of factor Xa inhibitors containing non-amidine S1 elements.
    Franciskovich JB; Masters JJ; Tinsley JM; Craft TJ; Froelich LL; Gifford-Moore DS; Klimkowski VJ; Smallwood JK; Smith GF; Smith T; Towner RR; Weir LC; Wiley MR
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4838-41. PubMed ID: 16140530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Development of New Factor Xa Inhibitors Based on Amide Synthesis.
    Tarasov DN; Tovbin DG; Malakhov DV; Aybush AV; Tserkovnikova NA; Savelyeva MI; Sychev DA; Drozd NN; Savchenko AY
    Curr Drug Discov Technol; 2018; 15(4):335-350. PubMed ID: 29468977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.
    Al-Horani RA; Mehta AY; Desai UR
    Eur J Med Chem; 2012 Aug; 54():771-83. PubMed ID: 22770607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of glycyrrhetinic acid as an orally active, direct inhibitor of blood coagulation factor xa.
    Jiang L; Wang Q; Shen S; Xiao T; Li Y
    Thromb Res; 2014 Mar; 133(3):501-6. PubMed ID: 24412029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor.
    Hara T; Yokoyama A; Morishima Y; Kunitada S
    Thromb Res; 1995 Oct; 80(1):99-104. PubMed ID: 8578544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors.
    Nagata T; Yoshino T; Haginoya N; Yoshikawa K; Isobe Y; Furugohri T; Kanno H
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4683-8. PubMed ID: 17555959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fragment-Based Lead Generation of 5-Phenyl-1
    Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.
    Escolar G; Diaz-Ricart M; Arellano-Rodrigo E
    Drugs Today (Barc); 2017 May; 53(5):271-282. PubMed ID: 28650000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
    Barrett YC; Wang Z; Frost C; Shenker A
    Thromb Haemost; 2010 Dec; 104(6):1263-71. PubMed ID: 20978714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel strategy to boost oral anticoagulant activity of blood coagulation enzyme inhibitors based on biotransformation into hydrophilic conjugates.
    Ishihara T; Koga Y; Mori K; Sugasawa K; Iwatsuki Y; Hirayama F
    Bioorg Med Chem; 2014 Nov; 22(22):6324-32. PubMed ID: 25438755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
    Ye B; Arnaiz DO; Chou YL; Griedel BD; Karanjawala R; Lee W; Morrissey MM; Sacchi KL; Sakata ST; Shaw KJ; Wu SC; Zhao Z; Adler M; Cheeseman S; Dole WP; Ewing J; Fitch R; Lentz D; Liang A; Light D; Morser J; Post J; Rumennik G; Subramanyam B; Sullivan ME; Vergona R; Walters J; Wang YX; White KA; Whitlow M; Kochanny MJ
    J Med Chem; 2007 Jun; 50(13):2967-80. PubMed ID: 17536795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological activity of amidinobicyclic compounds (derivatives of DX-9065a) as factor Xa inhibitors: SAR study of S1 and aryl binding sites.
    Komoriya S; Kanaya N; Nagahara T; Yokoyama A; Inamura K; Yokoyama Y; Katakura S; Hara T
    Bioorg Med Chem; 2004 May; 12(9):2099-114. PubMed ID: 15080912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cinnamylindoline derivatives: synthesis and factor Xa (FXa) inhibitory activities.
    Noguchi T; Tanaka N; Nishimata T; Goto R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1494-504. PubMed ID: 17917295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in serine protease inhibitors as anticoagulant agents.
    Prezelj A; Anderluh PS; Peternel L; Urleb U
    Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.
    Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Hase Y; Uchida I; Aisaka K; Katoh S; Cho H
    J Med Chem; 2005 May; 48(10):3586-604. PubMed ID: 15887966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations.
    Xu C; Ren Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4522-8. PubMed ID: 26343829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.